3 May, 2019, by clincapture-client
It’s common knowledge that not all Electronic Data Capture systems are created equal. Some systems better suit simpler phase I studies, while others are more equipped to handle complex phase II & III studies. In the past it has been fairly common to use a more affordable provider for phase I studies and then switch once studies get more complex. Since phase II & III studies are crucial for the success of a product, Sponsors usually want to use a provider that they can trust to handle the complexity of the trial. If a company is launching their first product and cannot afford an expensive leading Electronic Data Capture system, it can be hard to find a provider that can handle these more complex studies. What if we told you that you don’t have to switch systems after phase I?
Fortunately, ClinCapture believes in working with customers beyond phase I. Our sleek Electronic Data Capture platform “Captivate” is built to handle both easy and complex trials, meaning our customers can continue running their study on Captivate and avoid the headache of opting for an expensive alternative or a system that does not have the advanced capabilities they need.
Features you may need per phase:
If you are running a phase I study, you are probably looking for an Electronic Data Capture system that offers intuitive build designs, fast database go-live times, and a low monthly cost. This phase also benefits from do-it-yourself mid study changes.
If you are running a larger phase II or III study, you will probably need an Electronic Data Capture system that is scalable and has more advanced features, such as Form Versioning, flexible Risk-Based Monitoring (RBM) and Advanced Reporting with Business Intelligence (BI) Tools to allow for customizable reports and cross-study reporting.
If you are running a late phase study, you may be more focused on patient reported outcomes and the long-term cost of the study. With ClinCapture you can take advantage of our flexible eCOA/ePRO module that send customizable surveys directly to patients, clinicians, or caregivers. Additionally, ClinCapture offers specialized pricing structures for these types of studies.
ClinCapture is a high-quality Electronic Data Capture solution that handles ALL study phases, complex or simple, at 20% the cost of leading competitors! Learn more about ClinCapture’s comprehensive eClinical platform. You can request a consultation here to get started.
About the author
ClinCapture provides a powerful eClinical platform that enables sponsors and CROs to rapidly build and deploy studies, lower clinical trials costs, and streamline data capture processes. Offering a host of private cloud solutions, ClinCapture’s technologies help advance the evaluation and development of drugs, biologics, and devices that demonstrate promise for the diagnosis and/or treatment of a wide range of diseases or medical conditions. For more information, please visit clincapture.com or follow us at @ClinCapture.
16 March, 2020
Clinical Research for COVID-19With the pandemic of COVID-19, efforts to speed up treatments and develop a vaccine are increasing dramatically. Many companies have been repurposing antivirals while others are pursuing a more high-tech approach. With recent findings from Clover Biopharmaceuticals, COVID-19 is variegated with a protein aptly called ‘Spike’ (S) protein, allowing the virus to burrow into the cells of humans, ma
7 October, 2019
What’s Private Cloud Infrastructure (& Why Every EDC Provider Should Offer It)Sponsors and CROs - Do you know where your clinical trial database resides? Unless you have on-premises servers, your clinical trial database most likely resides on the cloud. The cloud is not a one-size-fits-all solution and can greatly affect various software aspects, such as software speed and performance. When choosing a
4 October, 2019
Have a restricted timeline for your study? Questions to ask your EDC provider.As a research organization, you are probably familiar with the strict guidelines to file a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) and other review processes. Since research companies are usually on a tight schedule for their products to reach the market before competitors, filing early is critical. This is most important if you a